A deleterious mutation was detected in 20 out of 77 healthy, unaffected probands (26%; 15 in BRCA1 and 5 in the BRCA2 gene) with a severe family history of breast and/or ovarian cancer but no living affected relative. This evidence concerns the gene BRCA2 and ovarian cancer.